The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
The Who, What, How, When, and Why of Using Mobile Technology in Clinical Trials
Robert A. DiCicco, PharmD
TransCelerate Biopharma Inc., United States
Panelists will discuss how they have implemented recommendations from CTTI’s Mobile Clinical Trials projects to advance the use of mobile technology in clinical trials, as well as how others can adopt these strategies.
Learning Objective : Describe recommendations for successfully incorporating mobile technology in regulatory submission trials; Identify approaches for developing novel endpoints, overcoming legal and regulatory barriers, and incorporating mobile devices in clinical trials while accounting for site and patient perspectives; Discuss opportunities to implement recommendations in attendee organizations.
Patients and Partners LLC, United States
Philip Coran, JD, MBA
Principal, Global Compliance and Strategy
Medidata Solutions, United States
Regulatory Counsel for Policy, OSI, CDER
FDA, United States